Nesa Medtech pioneers a scar-less solution for uterine fibroids

Read Time:1 Minute, 41 Second

October 13: Nesa Medtech, a medical device startup, has developed a novel scar-less solution for treating symptomatic uterine fibroids. It is the result of extensive research for many years. The procedure involves shrinking the fibroids using thermal energy performed under patented real-time image guidance and navigation system.

Medication is the first line of treatment; unfortunately, it is effective only in a small subset, i.e., less than 25% of cases. This makes the various surgical procedure the solution to treat fibroids. Unfortunately, hysterectomy, i.e., removal of the uterus, is the most common solution. This procedure is considered a major surgery that needs a long recovery time, usually a few weeks and has very high morbidity.  

There is a huge clinical need for an alternative to the current surgical method that significantly reduces the risks associated with the remedy of uterine fibroids. This is where the Nesa Medtech solution comes in. The scar-less solution promotes quicker recovery, has no surgical infection risk, and preserves the uterus.  

Sreekar Kothamachuthe Founder & CEO of Nesa Medtech, has more than 15 years of experience in the field. He realized uterine fibroids are significantly reducing women’s quality of life. He says, “The socio-economic burden of the problem is a much bigger problem than breast and cervical cancer.” This led Sreekar and his team to look for an efficient, safe, and scar-less solution. This revolutionary scar-less solution would help women with symptomatic fibroids recover quickly and preserve the uterus. 

Nesa Medtech is a proud alumnus of various global accelerator programs such as Medtech Innovator, Mass Medic Ignite, and, recently, M2D2 Impact. Although Nesa Medtech feels highly honored by the support coming their way, they understand the actual recognition is to be able to transform women’s health globally.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

The post Nesa Medtech pioneers a scar-less solution for uterine fibroids appeared first on Republic News Today.

Related Posts

Sri Priyanka Geo Commex Limited IPO Currently Open – A Globally Diversified Commodity-Focused Business with Operations Across India, Morocco & Singapore.

Mumbai (Maharashtra) [India], June 27:  Sri Priyanka Geo Commex Limited, a globally diversified, commodity-focused group engaged in the supply of critical minerals and the manufacturing of rice bran oil, with…

Aastha Spintex Limited IPO Opens on June 29, 2026

Mumbai (Maharashtra) [India], June 27: Aastha Spintex Limited, engaged in the business of manufacturing and trading of carded, combed and compact combed cotton yarns and cotton bales. Company proposes to…

You Missed

12 Exceptional Individuals Making a Difference

  • By
  • June 27, 2026
12 Exceptional Individuals Making a Difference

Dr. Vikas Singhal: A Global Voice in Healthcare, Research, Education and Integrative Medicine

  • By
  • June 26, 2026
Dr. Vikas Singhal: A Global Voice in Healthcare, Research, Education and Integrative Medicine

EFCCC Announces Juhi Shakya as Maharashtra State Vice President to Reinforce Statewide Environmental Initiatives

  • By
  • June 26, 2026
EFCCC Announces Juhi Shakya as Maharashtra State Vice President to Reinforce Statewide Environmental Initiatives

Dr. Surabhi Dhanwala on How Yoga Is Transforming Physiotherapy and Patient Recovery in India

  • By
  • June 26, 2026
Dr. Surabhi Dhanwala on How Yoga Is Transforming Physiotherapy and Patient Recovery in India

TradeFlock Launches List of the Best Education Leaders in India 2026

  • By
  • June 25, 2026
TradeFlock Launches List of the Best Education Leaders in India 2026

TradeFlock Launches List of the Best Education Leaders in India 2026

TradeFlock Launches List of the Best Education Leaders in India 2026